Liver Disease Clinical Trials

Showing 601-620 of 690 trials

Prevention of Hepatitis B Virus Reinfection After Liver Transplantation With Entecavir

NCT01046799

The purpose of this study is to determine whether hepatitis B immunoglobin can be discontinued early after hepatitis B virus (HBV) induced liver transplantation and be replaced by the nucleoside analogue entecavir to prevent hepatitis B reinfection.

Liver TransplantationHepatitis BLiver Disease

HepNet Study House, German Liverfoundation20 participantsStarted Mar 2008

Essen, Germany • Hanover, Germany • Heidelberg, Germany

TERMINATEDPHASE2/PHASE3

Daptomycin + Meropenem Versus Ceftazidime in the Treatment of Nosocomial Spontaneous Bacterial Peritonitis

NCT01455246

Nosocomial spontaneous bacterial peritonitis (SBP) is frequently caused by multi drug resistant bacteria. Standard treatment of SBP could be ineffective. The aim of the study is to compare daptomycin + meropenem vs ceftazidime in the treatment of nosocomial SBP.

CirrhosisAscitesNosocomial Spontaneous Bacterial Peritonitis

University of Padova32 participantsStarted Oct 2010

Padua, PD, Italy

Prevention of Hepatitis B Virus Reinfection After Liver Transplantation With Entecavir

Daptomycin + Meropenem Versus Ceftazidime in the Treatment of Nosocomial Spontaneous Bacterial Peritonitis

Related Searches

Prospective Study of Profile of Hepatic Osteodystrophy in Patients With Non-Choleastatic Liver Cirrhosis and Impact of Bisphosphonate Supplementation

HIV Liver Regeneration Project for HIV Patients With Cirrhosis by Autologous Bone Marrow Transplantation

Metoprolol Succinate in Cardiac Remodeling Related to Cirrhosis

Effects of Siliphos-Selenium-Methionine-Alpha Lipoic Acid in Patients With Fatty Liver and Non-alcoholic Steatohepatitis

Effects of Low-dose Maintenance Peg Interferon Alfa-2b Therapy Versus Supportive Care in Patients With Cirrhotic Hepatitis C With HIV (Study P04371)

Perindopril and Telmisartan for the Treatment of Nonalcoholic Fatty Liver Disease

Somatostatin Analogues as a Volume Reducing Treatment of Polycystic Livers (RESOLVE)

Lanreotide Autogel in the Treatment of Symptomatic Polycystic Liver Disease

Anidulafungin vs Amphotericin B Safety in High Risk Hepatic Transplant Recipients

Evaluation of Renal Blood Flow Using Contrast Enhanced Ultrasound for Differential Diagnosis of Acute Kidney Injury in Cirrhotic Patients: A Pilot Study

The Orange-III Trial: Optimised Recovery With Movicol® Preoperatively Within an Enhanced Recovery Programme

Transoesophageal Echocardiography in Liver Transplantation

A Dose-defining Study of OPC-41061 in Treatment of Hepatic Edema

A Trial to Investigate the Efficacy of OPC-41061 Administered at a Dose of 7.5 mg in Patients With Hepatic Edema

Comparison of the Hemostatic Patch to Fibrin Sealant (TachoSil®) in Subjects Undergoing Hepatic Surgery

To Evaluate the Efficacy and Safety of (18F-FCH) Comparing With (18F-FDG) for Detecting Hepatocellular Carcinoma

Trial of Hepaguard® in Adults With Nonalcoholic Steatohepatitis

Effect of Tolvaptan on Cognitive Function in Cirrhosis